These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32377280)

  • 21. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.
    Shah RB; Collier JS; Sayeed VA; Bryant A; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Sep; 11(3):1359-67. PubMed ID: 20740332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer.
    Ashrafpour R; Ayati N; Sadeghi R; Zare Namdar S; Ayati N; Ghahremani S; Zakavi SR
    Asia Ocean J Nucl Med Biol; 2018; 6(2):108-112. PubMed ID: 29998143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations.
    Nidanapu RP; Rajan S; Mahadevan S; Gitanjali B
    Paediatr Drugs; 2016 Dec; 18(6):451-463. PubMed ID: 27704404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microtomographic studies of subdivision of modified-release tablets.
    Wilczyński S; Koprowski R; Duda P; Banyś A; Błońska-Fajfrowska B
    Int J Pharm; 2016 Sep; 511(2):899-912. PubMed ID: 27480395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Fillers and Binders on the Accuracy of Tablet Subdivision.
    Pereira GRS; Taveira SF; Cunha-Filho M; Marreto RN
    AAPS PharmSciTech; 2018 Oct; 19(7):2929-2933. PubMed ID: 30120694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of medication dose uniformity in commonly split tablets.
    Teng J; Song CK; Williams RL; Polli JE
    J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breaking of scored tablets: a review.
    van Santen E; Barends DM; Frijlink HW
    Eur J Pharm Biopharm; 2002 Mar; 53(2):139-45. PubMed ID: 11879995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
    Casiraghi A; Musazzi UM; Franceschini I; Berti I; Paragò V; Cardosi L; Minghetti P
    Minerva Pediatr; 2014 Oct; 66(5):355-62. PubMed ID: 25253183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical counselling about different types of tablet-splitting methods based on the results of weighing tests and mechanical development of splitting devices.
    Somogyi O; Meskó A; Csorba L; Szabó P; Zelkó R
    Eur J Pharm Sci; 2017 Aug; 106():262-273. PubMed ID: 28606803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight and content uniformity of lorazepam half-tablets: A study of correlation of a low drug content product.
    Zaid AN; Al-Ramahi RJ; Ghoush AA; Qaddumi A; Zaaror YA
    Saudi Pharm J; 2013 Jan; 21(1):71-5. PubMed ID: 23960821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Certain Pharmaceutical Quality Attributes of Lisinopril Split Tablets.
    Fahelelbom KM; Al-Tabakha MM; Eissa NA; Javadi J
    Sci Pharm; 2016 Oct; 84(4):646-653. PubMed ID: 27727195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of tablet splitting in a Brazilian tertiary care hospital.
    Melo VV; Pereira GR; Soares AQ; Silva IC; Taveira SF; Cunha-Filho M; Marreto RN
    Pharm Pract (Granada); 2020; 18(2):1910. PubMed ID: 32566050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rationale of scored tablets as dosage form.
    Rodenhuis N; De Smet PA; Barends DM
    Eur J Pharm Sci; 2004 Feb; 21(2-3):305-8. PubMed ID: 14757502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are There Differences in the Homogeneity of the Parts of Tablets Obtained after Subdivision?-A Preliminary Assessment Using an X-ray Microtomography.
    Meisner M; Kuśnierz P; Duda P; Wilczyński S; Sarecka-Hujar B
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of pharmaceutical quality of furosemide tablets from multinational markets.
    Qureshi SA; McGilveray IJ
    Drug Dev Ind Pharm; 1998 Nov; 24(11):995-1005. PubMed ID: 9876554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of formulation variables on weight uniformity of scored tablets using factorial design.
    Zaid AN; Hawari R; Malkieh N; Natshih Y; Yousef A; Jaradat N; Hammad A; Basharat R
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2501-2507. PubMed ID: 31894042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosage variability of veterinary drug products, containing furosemide, linked to tablet splitting.
    Maggi L; Friuli V; Perugini P; Musitelli G; Venco L
    Open Vet J; 2021; 11(3):471-482. PubMed ID: 34722213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of Matrix Technology on the Subdivision of Sustained Release Matrix Tablets.
    Teixeira MT; Sa-Barreto LL; Taveira SF; Gratieri T; Gelfuso GM; Marreto RN; Silva IC; Cunha-Filho M
    AAPS PharmSciTech; 2019 Dec; 21(1):8. PubMed ID: 31797144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Newly Designed and Traditional Punches in Manufacturing of Scored ODTs.
    Palugan L; Moutaharrik S; Maroni A; Foppoli AA; Melocchi A; Vecchio C; Gazzaniga A; Cerea M
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical analysis of tablet breakability methods.
    Van Vooren L; De Spiegeleer B; Thonissen T; Joye P; Van Durme J; Slegers G
    J Pharm Pharm Sci; 2002; 5(2):190-8. PubMed ID: 12207873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.